CARDIOCOMM SOLUTIONS INC (EKG.CA) Stock Income Statement
Canada - TSX Venture Exchange - TSX-V:EKG - CA14159N2086 - Common Stock
0.01 CAD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 482.40K | 526.70K | 876.40K | 995.80K | 682.50K | |||
| Cost Of Goods | 50.00K | 30.00K | 140.00K | 268.40K | 71.70K | |||
| Gross Profit | 435.80K | 500.60K | 737.40K | 727.50K | 610.90K | |||
| Operating Expenses | 764.10K | 791.50K | 944.40K | 804.80K | 822.70K | |||
| Research and Development | N/A | N/A | N/A | 0.00 | 11.10K | |||
| Selling, General, and Administrative Expenses | 780.00K | 760.00K | 920.00K | 776.10K | 782.90K | |||
| Operating Income | -334.10K | -291.50K | -204.40K | -77.40K | -211.90K | |||
| Interest Income/Expense | -55.90K | -38.50K | -64.30K | -29.30K | -35.30K | |||
| Other Income/Expense | 60.00K | 140.00K | 170.00K | 104.20K | 266.20K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | -18.70K | |||
| Income Before Taxes | -310.00K | -190.00K | -100.00K | -2.50K | 300.00 | |||
| Net Income | -310.00K | -190.00K | -100.00K | -2.50K | 300.00 | |||
| EBITDA | N/A | -261.50K | -184.40K | -48.70K | -183.30K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | 90.34% | 95.04% | 84.14% | 73.06% | 89.51% | |||
| Profit Margin | -64.26% | -36.07% | -11.41% | -0.25% | 0.04% | |||
| Operating Profit Margin | -69.26% | -55.34% | -23.32% | -7.77% | -31.05% | |||
All data in CAD